Global Antibody Sequencing Industry

Global Antibody Sequencing Industry Research & Trends Analysis Report

Global Antibody Sequencing Industry

Global Antibody Sequencing Industry Research & Trends Analysis Report


Insights into the Antibody Sequencing Market include supply chain optimization, Antibody Sequencing challenges, and growth forecasts segmented by region and service type.

Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!

According to Market IntelliX Research, the global market for Antibody Sequencing should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.

China Antibody Sequencing market should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.

The United States Antibody Sequencing market should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.

In terms of type, Monoclonal Antibodies segment holds a share about % in 2023 and will reach % in 2030; while in terms of application, Academic and Research Institutions has a share approximately % in 2023 and will grow at a CAGR % during 2024 and 2030.

The global key manufacturers of Antibody Sequencing include Nanjing Mingyan Biotechnology Co., Ltd., Suzhou Jinweizhi Biotechnology Co., Ltd., Beijing Baitai Parker Biotechnology Co., Ltd., Biocompare, Abveris, Rapid Novor, GenScript, Absolute Antibody and Curia Global, etc. In 2023, the global top five players hold a share approximately % in terms of revenue.

This report aims to provide a comprehensive study of the global market for Antibody Sequencing. Report Highlights:

(1) Global Antibody Sequencing market size (value),history data from 2019-2024 and forecast data from 2024 to 2030.

(2) Global Antibody Sequencing market competitive situation, revenue and market share, from 2018 to 2022.

(3) China Antibody Sequencing market competitive situation, revenue and market share, from 2018 to 2022.

(4) Global Antibody Sequencing segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.

(5) Global Antibody Sequencing segment by type and by application and regional segment by type and by application.

(6) Antibody Sequencing industry supply chain, upstream, midstream and downstream analysis.

Market segment by regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)

South America (Brazil, Rest of South America)

Middle East & Africa

Market segment by type, covers

Monoclonal Antibodies

Polyclonal Antibodies

Market segment by application, can be divided into

Academic and Research Institutions

Pharmaceutical and Biotech Companies

Diagnostic and Clinical Laboratories

Other

Market segment by players, this report covers

Nanjing Mingyan Biotechnology Co., Ltd.

Suzhou Jinweizhi Biotechnology Co., Ltd.

Beijing Baitai Parker Biotechnology Co., Ltd.

Biocompare

Abveris

Rapid Novor

GenScript

Absolute Antibody

Curia Global

ProteoGenix

CiteAb

BIOZOL

1 Market Overview

1.1 Product Overview and Scope of Antibody Sequencing

1.2 Global Antibody Sequencing Market Size and Forecast

1.3 China Antibody Sequencing Market Size and Forecast

1.4 China Market Percentage in Global

1.4.1 By Revenue, China Antibody Sequencing Share in Global Market, 2019-2030

1.4.2 Antibody Sequencing Market Size: China VS Global, 2019-2030

1.5 Antibody Sequencing Market Dynamics

1.5.1 Antibody Sequencing Market Drivers

1.5.2 Antibody Sequencing Market Restraints

1.5.3 Antibody Sequencing Industry Trends

1.5.4 Antibody Sequencing Industry Policy

2 Global Competitive Situation by Company

2.1 Global Antibody Sequencing Revenue by Company (2019-2024)

2.2 Global Antibody Sequencing Participants, Market Position (Tier 1, Tier 2 and Tier 3)

2.3 Global Antibody Sequencing Concentration Ratio

2.4 Global Antibody Sequencing Mergers & Acquisitions, Expansion Plans

2.5 Global Antibody Sequencing Manufacturers Product Type

3 China Competitive Situation by Company

3.1 China Antibody Sequencing Revenue by Company (2019-2024)

3.2 China Antibody Sequencing Antibody Sequencing Participants, Market Position (Tier 1, Tier 2 and Tier 3)

3.3 China Antibody Sequencing, Revenue Percentage of Local Players VS Foreign Manufacturers (2019-2024)

4 Industry Chain Analysis

4.1 Antibody Sequencing Industry Chain

4.2 Antibody Sequencing Upstream Analysis

4.3 Antibody Sequencing Midstream Analysis

4.4 Antibody Sequencing Downstream Analysis

5 Sights by Type

5.1 Antibody Sequencing Classification

5.1.1 Monoclonal Antibodies

5.1.2 Polyclonal Antibodies

5.2 By Type, Global Antibody Sequencing Market Size & CAGR, 2019 VS 2024 VS 2030

5.3 By Type, Global Antibody Sequencing Revenue, 2019-2030

6 Sights by Application

6.1 Antibody Sequencing Segment by Application

6.1.1 Academic and Research Institutions

6.1.2 Pharmaceutical and Biotech Companies

6.1.3 Diagnostic and Clinical Laboratories

6.1.4 Other

6.2 By Application, Global Antibody Sequencing Market Size & CAGR, 2019 VS 2024 VS 2030

6.3 By Application, Global Antibody Sequencing Revenue, 2019-2030

7 Sales Sights by Region

7.1 By Region, Global Antibody Sequencing Market Size, 2019 VS 2024 VS 2030

7.2 By Region, Global Antibody Sequencing Market Size, 2019-2030

7.3 North America

7.3.1 North America Antibody Sequencing Market Size & Forecasts, 2019-2030

7.3.2 By Country, North America Antibody Sequencing Market Size Market Share

7.4 Europe

7.4.1 Europe Antibody Sequencing Market Size & Forecasts, 2019-2030

7.4.2 By Country, Europe Antibody Sequencing Market Size Market Share

7.5 Asia Pacific

7.5.1 Asia Pacific Antibody Sequencing Market Size & Forecasts, 2019-2030

7.5.2 By Country/Region, Asia Pacific Antibody Sequencing Market Size Market Share

7.6 South America

7.6.1 South America Antibody Sequencing Market Size & Forecasts, 2019-2030

7.6.2 By Country, South America Antibody Sequencing Market Size Market Share

7.7 Middle East & Africa

8 Sights by Country Level

8.1 By Country, Global Antibody Sequencing Market Size & CAGR，2019 VS 2024 VS 2030

8.2 By Country, Global Antibody Sequencing Market Size, 2019-2030

8.3 U.S.

8.3.1 U.S. Antibody Sequencing Market Size, 2019-2030

8.3.2 By Company, U.S. Antibody Sequencing Revenue Market Share, 2019-2024

8.3.3 By Type, U.S. Antibody Sequencing Revenue Market Share, 2023 VS 2030

8.3.4 By Application, U.S. Antibody Sequencing Revenue Market Share, 2023 VS 2030

8.4 Europe

8.4.1 Europe Antibody Sequencing Market Size, 2019-2030

8.4.2 By Company, Europe Antibody Sequencing Revenue Market Share, 2019-2024

8.4.3 By Type, Europe Antibody Sequencing Revenue Market Share, 2023 VS 2030

8.4.4 By Application, Europe Antibody Sequencing Revenue Market Share, 2023 VS 2030

8.5 China

8.5.1 China Antibody Sequencing Market Size, 2019-2030

8.5.2 By Company, China Antibody Sequencing Revenue Market Share, 2019-2024

8.5.3 By Type, China Antibody Sequencing Revenue Market Share, 2023 VS 2030

8.5.4 By Application, China Antibody Sequencing Revenue Market Share, 2023 VS 2030

8.6 Japan

8.6.1 Japan Antibody Sequencing Market Size, 2019-2030

8.6.2 By Company, Japan Antibody Sequencing Revenue Market Share, 2019-2024

8.6.3 By Type, Japan Antibody Sequencing Revenue Market Share, 2023 VS 2030

8.6.4 By Application, Japan Antibody Sequencing Revenue Market Share, 2023 VS 2030

8.7 South Korea

8.7.1 South Korea Antibody Sequencing Market Size, 2019-2030

8.7.2 By Company, South Korea Antibody Sequencing Revenue Market Share, 2019-2024

8.7.3 By Type, South Korea Antibody Sequencing Revenue Market Share, 2023 VS 2030

8.7.4 By Application, South Korea Antibody Sequencing Revenue Market Share, 2023 VS 2030

8.8 Southeast Asia

8.8.1 Southeast Asia Antibody Sequencing Market Size, 2019-2030

8.8.2 By Company, Southeast Asia Antibody Sequencing Revenue Market Share, 2019-2024

8.8.3 By Type, Southeast Asia Antibody Sequencing Revenue Market Share, 2023 VS 2030

8.8.4 By Application, Southeast Asia Antibody Sequencing Revenue Market Share, 2023 VS 2030

8.9 India

8.9.1 India Antibody Sequencing Market Size, 2019-2030

8.9.2 By Company, India Antibody Sequencing Revenue Market Share, 2019-2024

8.9.3 By Type, India Antibody Sequencing Revenue Market Share, 2023 VS 2030

8.9.4 By Application, India Antibody Sequencing Revenue Market Share, 2023 VS 2030

8.10 Middle East & Asia

8.10.1 Middle East & Asia Antibody Sequencing Market Size, 2019-2030

8.10.2 By Company, Middle East & Asia Antibody Sequencing Revenue Market Share, 2019-2024

8.10.3 By Type, Middle East & Asia Antibody Sequencing Revenue Market Share, 2023 VS 2030

8.10.4 By Application, Middle East & Asia Antibody Sequencing Revenue Market Share, 2023 VS 2030

9 Global Manufacturers Profile

9.1 Nanjing Mingyan Biotechnology Co., Ltd.

9.1.1 Nanjing Mingyan Biotechnology Co., Ltd. Company Information, Head Office, Market Area and Industry Position

9.1.2 Nanjing Mingyan Biotechnology Co., Ltd. Company Profile and Main Business

9.1.3 Nanjing Mingyan Biotechnology Co., Ltd. Antibody Sequencing Models, Specifications and Application

9.1.4 Nanjing Mingyan Biotechnology Co., Ltd. Antibody Sequencing Revenue and Gross Margin, 2019-2024

9.1.5 Nanjing Mingyan Biotechnology Co., Ltd. Recent Developments

9.2 Suzhou Jinweizhi Biotechnology Co., Ltd.

9.2.1 Suzhou Jinweizhi Biotechnology Co., Ltd. Company Information, Head Office, Market Area and Industry Position

9.2.2 Suzhou Jinweizhi Biotechnology Co., Ltd. Company Profile and Main Business

9.2.3 Suzhou Jinweizhi Biotechnology Co., Ltd. Antibody Sequencing Models, Specifications and Application

9.2.4 Suzhou Jinweizhi Biotechnology Co., Ltd. Antibody Sequencing Revenue and Gross Margin, 2019-2024

9.2.5 Suzhou Jinweizhi Biotechnology Co., Ltd. Recent Developments

9.3 Beijing Baitai Parker Biotechnology Co., Ltd.

9.3.1 Beijing Baitai Parker Biotechnology Co., Ltd. Company Information, Head Office, Market Area and Industry Position

9.3.2 Beijing Baitai Parker Biotechnology Co., Ltd. Company Profile and Main Business

9.3.3 Beijing Baitai Parker Biotechnology Co., Ltd. Antibody Sequencing Models, Specifications and Application

9.3.4 Beijing Baitai Parker Biotechnology Co., Ltd. Antibody Sequencing Revenue and Gross Margin, 2019-2024

9.3.5 Beijing Baitai Parker Biotechnology Co., Ltd. Recent Developments

9.4 Biocompare

9.4.1 Biocompare Company Information, Head Office, Market Area and Industry Position

9.4.2 Biocompare Company Profile and Main Business

9.4.3 Biocompare Antibody Sequencing Models, Specifications and Application

9.4.4 Biocompare Antibody Sequencing Revenue and Gross Margin, 2019-2024

9.4.5 Biocompare Recent Developments

9.5 Abveris

9.5.1 Abveris Company Information, Head Office, Market Area and Industry Position

9.5.2 Abveris Company Profile and Main Business

9.5.3 Abveris Antibody Sequencing Models, Specifications and Application

9.5.4 Abveris Antibody Sequencing Revenue and Gross Margin, 2019-2024

9.5.5 Abveris Recent Developments

9.6 Rapid Novor

9.6.1 Rapid Novor Company Information, Head Office, Market Area and Industry Position

9.6.2 Rapid Novor Company Profile and Main Business

9.6.3 Rapid Novor Antibody Sequencing Models, Specifications and Application

9.6.4 Rapid Novor Antibody Sequencing Revenue and Gross Margin, 2019-2024

9.6.5 Rapid Novor Recent Developments

9.7 GenScript

9.7.1 GenScript Company Information, Head Office, Market Area and Industry Position

9.7.2 GenScript Company Profile and Main Business

9.7.3 GenScript Antibody Sequencing Models, Specifications and Application

9.7.4 GenScript Antibody Sequencing Revenue and Gross Margin, 2019-2024

9.7.5 GenScript Recent Developments

9.8 Absolute Antibody

9.8.1 Absolute Antibody Company Information, Head Office, Market Area and Industry Position

9.8.2 Absolute Antibody Company Profile and Main Business

9.8.3 Absolute Antibody Antibody Sequencing Models, Specifications and Application

9.8.4 Absolute Antibody Antibody Sequencing Revenue and Gross Margin, 2019-2024

9.8.5 Absolute Antibody Recent Developments

9.9 Curia Global

9.9.1 Curia Global Company Information, Head Office, Market Area and Industry Position

9.9.2 Curia Global Company Profile and Main Business

9.9.3 Curia Global Antibody Sequencing Models, Specifications and Application

9.9.4 Curia Global Antibody Sequencing Revenue and Gross Margin, 2019-2024

9.9.5 Curia Global Recent Developments

9.10 ProteoGenix

9.10.1 ProteoGenix Company Information, Head Office, Market Area and Industry Position

9.10.2 ProteoGenix Company Profile and Main Business

9.10.3 ProteoGenix Antibody Sequencing Models, Specifications and Application

9.10.4 ProteoGenix Antibody Sequencing Revenue and Gross Margin, 2019-2024

9.10.5 ProteoGenix Recent Developments

9.11 CiteAb

9.11.1 CiteAb Company Information, Head Office, Market Area and Industry Position

9.11.2 CiteAb Company Profile and Main Business

9.11.3 CiteAb Antibody Sequencing Models, Specifications and Application

9.11.4 CiteAb Antibody Sequencing Revenue and Gross Margin, 2019-2024

9.11.5 CiteAb Recent Developments

9.12 BIOZOL

9.12.1 BIOZOL Company Information, Head Office, Market Area and Industry Position

9.12.2 BIOZOL Company Profile and Main Business

9.12.3 BIOZOL Antibody Sequencing Models, Specifications and Application

9.12.4 BIOZOL Antibody Sequencing Revenue and Gross Margin, 2019-2024

9.12.5 BIOZOL Recent Developments

10 Conclusion

11 Appendix

11.1 Research Methodology

11.2 Data Source

11.2.1 Secondary Sources

11.2.2 Primary Sources

11.3 Market Estimation Model

11.4 Disclaimer

Tables & Figures:
Show more
Research Methodology:
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.
Antibody Sequencing Market Size Estimation

To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.

Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.

Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.

We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.

Data Source

Secondary Sources

This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.

These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.

Market Size
  • Segmental value
  • Geographic Penetration
  • Product Adoption Rate for Different market
  • Journals, Websites, and Press Releases
  • Annual Reports and SEC Filings
  • Company Websites and Press Releases
  • Public and Paid Databases
  • Market Intellix Data Repository
Market Position of Top Company
  • Product Financials
  • Geographic value Mix
  • Total Company value
  • Business/Segmental value Mix
Qualitative Analysis
  • Influence Factors
  • Market Potential
  • Market Risks and Opportunities
  • Industry Trends
  • Geographical Features
  • Government Policies
  • Company Websites and Press Releases
  • Public and Paid Databases
  • Annual Reports
  • Industry Associations
  • Market Intellix Data Repository

Primary Sources

As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.

On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.

These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.

Key Data Information from Primary Sources

Primary Sources Parameters Key Data
Market Segments(by Application, by Type)
  • Value by Type
  • Status and Forecast
  • Value by Application
  • Value by Regions, Status and Forecast (2025-2031)
  • Value Market Share by Type
  • Value Growth Rate by Type
  • Value by Application
  • Percentage and Growth Rate by Application
  • Value Growth Rate and Market Share by Regions
  • Market Size Status and Forecast (2025-2031)
Total Market
  • Overall Size, Status and Forecast
  • Market Size Status and Forecast (2025-2031)
Frequently asked questions(FAQ's):
How are players chosen for the research coverage of the Antibody Sequencing Market study?
MI used a variety of industry standards such as NAICS, ICB, TRIC, and others to identify functional players in the industry, which they then shortlist and validate in an iterative process to finalize the most relevant players.
What is the expected rate of growth in the Antibody Sequencing Market?
From 2025 to 2030, the Antibody Sequencing Market is expected to grow at a compound annual growth rate of YY%, reaching a value of USD XXX Million.
In the current situation, what value does the Antibody Sequencing Market have?
The value of the Antibody Sequencing Market is estimated to be USD XXX million.
What are the top priorities for the growth of the Antibody Sequencing Market?
In this highly competitive and rapidly evolving Antibody Sequencing Industry, top strategic priorities such as innovation, diversification, and M&A would remain consistent.